Clinical and morphological characteristic of kidney damage in HIV/HCV co-infected patients who did not receive antiretroviral therapy

Main Article Content

A.I. Gorodetska
O.O. Dyadyk
M.D. Ivanova


In the era of antiretroviral therapy (ART), the development of chronic kidney disease in HIV-infected patients is a significant complication not directly related to acquired immunodeficiency syndrome (AIDS), the risk of which is increased with co-infection with hepatitis C virus (HCV). The pathogenetic pathways of the development of kidney tissue damage and the formation of a morphological substrate for each of the viruses are different, but the immune-mediated mechanisms are a common link for the development of immune complex diseases. We studied renal necropsy samples in 20 patients with HIV/HCV co-infection who did not receive ART, and the dependence of the identified morphological substrate on the level of CD4+ in the blood, to assess and predict their morphogenesis. We observed predominantly segmental mesangial proliferation with an expansion of the mesangial matrix and glomerular involvement ≥ 50 % in 15 (75 %) cases and glomerular involvement < 50 % in 3 (15 %) cases. Endocapillary proliferation (E), infiltration of glomeruli with monocytes, neutrophil leukocytes, segmental macrophages were found in 2 (10 %) cases with the involvement of ≥ 50 % of glomeruli, which was regarded as an exudative component of the inflammatory response. In all cases, sclerosis of capillary loops was verified, which was mainly accompanied by their collapse, thickening of the capillary walls, namely the basement membranes of capillaries and segmental sclerosis of capillary loops of the glo­meruli of varying severity. Initial interstitial stromal fibrosis was found in 5 (25 %) cases, degenerative changes in the convoluted tubules — in 9 (45 %), mainly with the T0–T1 level. Positive expression of IgA, IgM, IgG, and C3 complement fractions in the form of linear and granular deposits along the capillary endothelium was detected with an intensity of “+” to “++”. We compared the verified morphological pattern and the level of CD4+ in the blood and found that patients with deeper immunosuppression show fewer changes, mainly characterized as sclerotic. Moreover, with an increase in the level of CD4+, the morphological substrate is enriched with a proliferative component. Expression of immunoglobulins and components of the complement system in immonohistochemical assay, in particular in areas of sclerotic changes, verifies the presence of prolonged immune complex associated lesions. To determine the detailed morphogenesis, it is advisable to perform a further correlation analysis of the data obtained with the control.

Article Details

How to Cite
Gorodetska, A., O. Dyadyk, and M. Ivanova. “Clinical and Morphological Characteristic of Kidney Damage in HIV/HCV Co-Infected Patients Who Did Not Receive Antiretroviral Therapy”. KIDNEYS, vol. 10, no. 2, Aug. 2021, pp. 58-64, doi:10.22141/2307-1257.10.2.2021.234320.
Original Articles


Wyatt CM, Malvestutto C, Coca SG, Klotman PE, Parikh CR. The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysis. AIDS. 2008 Sep 12;22(14):1799-807. doi: 10.1097/QAD.0b013e32830e0152.

Wyatt CM. Kidney Disease and HIV Infection. Top Antivir Med. 2017 Feb/Mar;25(1):13-16.

Rossi C, Raboud J, Walmsley S, et al; Canadian Observational Cohort (CANOC) Collaboration. Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy. BMC Infect Dis. 2017 Apr 4;17(1):246. doi: 10.1186/s12879-017-2350-8.

Izzedine H, Sene D, Cacoub P, et al. Kidney diseases in HIV/HCV-co-infected patients. AIDS. 2009 Jun 19;23(10):1219-26. doi: 10.1097/QAD.0b013e32832ac36a.

Bruggeman LA, Nelson PJ. Controversies in the pathogenesis of HIV-associated renal diseases. Nat Rev Nephrol. 2009 Oct;5(10):574-81. doi: 10.1038/nrneph.2009.139.

Cohen SD, Kopp JB, Kimmel PL. Kidney Diseases Associated with Human Immunodeficiency Virus Infection. N Engl J Med. 2017 Dec 14;377(24):2363-2374. doi: 10.1056/NEJMra1508467.

Shmagel KV, Shmagel NG, Chereshnev VA. Immunity activation In HIV infection. Medical Immunology (Russia). 2017;19(5):489-504. doi: 10.15789/1563-0625-2017-5-489-504. (in russian).

Ketlinsky SA. Humoral immune response to HIV-1 infection and altered function of B lymphocytes.  Medical Immunology (Russia). 2012;14(3):183-188. doi: 10.15789/1563-0625-2012-3-183-188.

Sansonno D, Lauletta G, Montrone M, Grandaliano G, Schena FP, Dammacco F. Hepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture microdissection. Clin Exp Immunol. 2005 Jun;140(3):498-506. doi: 10.1111/j.1365-2249.2005.02778.x.

André P, Komurian-Pradel F, Deforges S, et al. Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol. 2002 Jul;76(14):6919-28. doi: 10.1128/jvi.76.14.6919-6928.2002.

Kolesnik, Nepomniachtchi V, Samuseva E. Morphological classification of renal diseases. Available from: Accessed: 2017 Jul.

Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney inter Suppl. 2012;2(1):1-138. doi: 10.1038/kisup.2012.6.

Haas M, Rastaldi MP, Fervenza FC. Histologic classification of glomerular diseases: clinicopathologic correlations, limitations exposed by validation studies, and suggestions for modification. Kidney Int. 2014 Apr;85(4):779-93. doi: 10.1038/ki.2013.375.

Huang X, Ma L, Ren P, et al. Updated Oxford classification and the international study of kidney disease in children classification: application in predicting outcome of Henoch-Schönlein purpura nephritis. Diagn Pathol. 2019 May 10;14(1):40. doi: 10.1186/s13000-019-0818-0.

Wang M, Wang R, He X, et al. Using MEST-C Scores and the International Study of Kidney Disease in Children Classification to Predict Outcomes of Henoch-Schönlein Purpura Nephritis in Children. Front Pediatr. 2021 Apr 14;9:658845. doi: 10.3389/fped.2021.658845.

Alamartine E, Sauron C, Laurent B, Sury A, Seffert A, Mariat C. The use of the Oxford classification of IgA nephropathy to predict renal survival. Clin J Am Soc Nephrol. 2011 Oct;6(10):2384-8. doi: 10.2215/CJN.01170211.

Salim SA, author; Batuman V, editor. What is the MEST-C score for immunoglobulin A (IgA) nephropathy? Available from: Accessed: May 19, 2020.

Saidakova, EV, Shmagel, KV, Korolevskaya, LB. et al. CD4+ T-Cell Cycling in HIV-Infected Patients with the Discordant Immunologic Response to the Antiretroviral Therapy. Cell Tiss. Biol. 2019;13:55-63. doi: 10.1134/S1990519X19010097.

Shmagel KV, Shmagel NG, Chereshnev VA. Immunity activation In HIV infection. Medical Immunology (Russia). 2017;19(5):489-504. doi: 10.15789/1563-0625-2017-5-489-504. (in russian).

Alter G, Moody MA. The humoral response to HIV-1: new insights, renewed focus. J Infect Dis. 2010 Oct 15;202 Suppl 2(Suppl 2):S315-22. doi: 10.1086/655654.

Most read articles by the same author(s)

1 2 > >>